Featured Interviews

UPDATE: Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)

Dr. Alen Davidoff provided an update on his previous interview from August 2020. Xortx just announced a recent grant on their European patent as well as other activity in the market. The company is hoping to start on their phase III trial on their autosomal dominant polycystic kidney disease program in the next quarter as well as up-list to a higher-tiered US exchange. […]

Featured Interviews

CanaQuest Medical Corp (OTC: CANQF)

ABOUT: CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)

Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. […]